MassMutual Private Wealth & Trust’s Iovance Biotherapeutics IOVA Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-356	Closed	-$1.19K	–	2422
2025 Q1	$1.19K	Buy	+356	New	+$1.84K	﹤0.01%	2079
2024 Q3	–	Sell	-28	Closed	-$225	–	2203
2024 Q2	$225	Sell	28 -19	-40%	-$204	﹤0.01%	2064
2024 Q1	$697	Buy	+47	New	+$547	﹤0.01%	1790
2023 Q3	–	Sell	-231	Closed	-$1.63K	–	1998
2023 Q2	$1.63K	Hold	231	–	–	﹤0.01%	1529
2023 Q1	$1.41K	Hold	231	–	–	﹤0.01%	1514
2022 Q4	$1K	Buy	231 +179	+344%	+$1.4K	﹤0.01%	1470
2022 Q3	$0	Hold	52	–	–	﹤0.01%	1710
2022 Q2	$1K	Buy	+52	New	+$681	﹤0.01%	1331

Other funds holding IOVA

MFM

MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MassMutual Private Wealth & Trust's IOVA Position: Q2 2025 in Review

MassMutual Private Wealth & Trust sold out of Iovance Biotherapeutics (IOVA) in Q2 2025, closing a stake of 356 shares — an estimated $1.19K sold.

MassMutual Private Wealth & Trust first reported a position in IOVA in Q2 2022 and held it in 8 quarters. The position peaked at $1.63K in Q2 2023. 254 funds tracked by Wall St. Rank hold IOVA as of Q2 2025.

MassMutual Private Wealth & Trust reported no remaining Iovance Biotherapeutics position as of Q2 2025 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 356 Iovance Biotherapeutics shares in Q2 2025, an estimated $1.19K.
MassMutual Private Wealth & Trust first reported a position in Iovance Biotherapeutics in Q2 2022 and held it in 8 quarters.
MassMutual Private Wealth & Trust's Iovance Biotherapeutics position peaked at $1.63K in Q2 2023.
254 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2025.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2025, filed 9 Jul 2025.